VENTRUS BIOSCIENCES INC Financials
moreView todays social media effects on VTUSView the latest stocks trending across Twitter. Click to view dashboardSee who Ventrus is hiring next, click here to view […]
moreView todays social media effects on VTUSView the latest stocks trending across Twitter. Click to view dashboardSee who Ventrus is hiring next, click here to view […]
moreView todays social media effects on VTUSView the latest stocks trending across Twitter. Click to view dashboardSee who Ventrus is hiring next, click here to view […]
[GlobeNewswire] – NEW YORK — Ventrus Biosciences, Inc. , a pharmaceutical company focused on developing and commercializing gastrointestinal products, today announced that, in response to a request from the company, the … moreView todays social media effects on VTUSView the latest stocks trending across Twitter. Click to view dashboardSee who Ventrus is hiring next, click here to view […]
moreView todays social media effects on VTUSView the latest stocks trending across Twitter. Click to view dashboardSee who Ventrus is hiring next, click here to view […]
[GlobeNewswire] – NEW YORK — Ventrus Biosciences, Inc. today announced top line efficacy and safety results from the second Phase 3 clinical trial of Diltiazem Hydrochloride 2% Cream (VEN 307) in patients with pain related … moreView todays social media effects on VTUSView the latest stocks trending across Twitter. Click to view dashboardSee who Ventrus is hiring next, click here […]
[at noodls] – NEW YORK, Feb. 11, 2013 (GLOBE NEWSWIRE) — Ventrus Biosciences, Inc. (Nasdaq:VTUS), a pharmaceutical company focused on developing and commercializing gastrointestinal products, today announced that Dr. … moreView todays social media effects on VTUSView the latest stocks trending across Twitter. Click to view dashboardSee who Ventrus is hiring next, click here to view […]
[at noodls] – NEW YORK, Feb. 7, 2013 (GLOBE NEWSWIRE) — Ventrus Biosciences, Inc. (Nasdaq:VTUS) today announced that the underwriter of its previously announced public offering of common stock has exercised in full … moreView todays social media effects on VTUSView the latest stocks trending across Twitter. Click to view dashboardSee who Ventrus is hiring next, click here to view […]
[at noodls] – NEW YORK, Jan. 29, 2013 (GLOBE NEWSWIRE) — Ventrus Biosciences, Inc. (Nasdaq:VTUS) announced today that it is concurrently offering to sell, subject to market and other conditions, (i) shares of its common … moreView todays social media effects on VTUSView the latest stocks trending across Twitter. Click to view dashboardSee who Ventrus is hiring next, click here […]
[at noodls] – NEW YORK, Nov. 13, 2012 (GLOBE NEWSWIRE) — Ventrus Biosciences, Inc. (Nasdaq:VTUS) today reported financial results for the third quarter ended September 30, 2012….This is an abstract of the original … moreView todays social media effects on VTUSView the latest stocks trending across Twitter. Click to view dashboard […]
[ACN Newswire] – By Jake KingAs expected, the FDA will require Ventrus Biosciences (NASDAQ:VTUS) to complete a second Phase III study of diltiazem hydrochloride cream (VEN-307) before submitting a New Drug Application … moreView todays social media effects on VTUSView the latest stocks trending across Twitter. Click to view dashboard […]